FORMULASI DAN EVALUASI NANOSTRUCTURED LIPID CARRIER (NLC) SPIRONOLAKTON
Spironolactone is a drug that commonly used to treat hypertension and edema conditions. Additionally, spironolactone also had an effect as antiandrogenic, potentially in the treatment of androgenic alopecia. Target og spironolactone for the treatment of androgenic alopecia is hair follicles. The...
Saved in:
| Main Author: | |
|---|---|
| Format: | Final Project |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/44554 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |
| Summary: | Spironolactone is a drug that commonly used to treat hypertension and edema conditions.
Additionally, spironolactone also had an effect as antiandrogenic, potentially in the treatment of
androgenic alopecia. Target og spironolactone for the treatment of androgenic alopecia is hair
follicles. The application is used topically. It aims to reduce the dose of medication that can use
systemic toxicity when administrated orally. One method used to maximize the delivery of
spironolactone to the hair follicle is nano-sized lipid carrier, the NLC (Nanostructured Lipid Carrier).
NLC is a typed of colloidal drug delivery systems, generated through the mixing of the solid lipid dan
liquid lipid. This study aimed to develop formula of NLC spironolactone in order to fulfill the various
parameters. NLC created by using high speed homogenization ultra turax and sonicated using a probe
sonicator. The experiment began with the selection of a couple of solid lipid (glyceryl monostearate,
cera alba, stearic acid, cetyl alcohol) and liquid lipid (oleic acid, virgin coconut oil and olive oil). The
proceed with the selection of a surfactant (Tween 80, Plantacare, Tegocare). Spironolactone NLC
evaluation include organoleptic, analysis of particle size, polydispersity index, the efficiency of
entrapment and physical stability during storage. NLC Spironolactone was produced in 4,5% glyceryl
monostearate, 1,5% oleic acid and 2% Plantacare with 1% active ingredient. Established composition
of spironolactone loaded NLC was used for this study, resulting particle size of 137,87 ± 2,46 nm,
polidispersity index of 0,29 ± 0,01, potential zeta of -2,13 mV and entrapment efficiency of 91,3%. NLC
stability test result for several days showed increasing of particle size but still within the target range.
|
|---|